C

Cadrenal Therapeutics Inc
NASDAQ:CVKD

Watchlist Manager
Cadrenal Therapeutics Inc
NASDAQ:CVKD
Watchlist
Price: 7.085 USD -0.35%
Market Cap: 14.7m USD

Wall Street
Price Targets

CVKD Price Targets Summary
Cadrenal Therapeutics Inc

Wall Street analysts forecast CVKD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CVKD is 36.38 USD with a low forecast of 30.3 USD and a high forecast of 47.25 USD.

Lowest
Price Target
30.3 USD
328% Upside
Average
Price Target
36.38 USD
413% Upside
Highest
Price Target
47.25 USD
567% Upside
Cadrenal Therapeutics Inc Competitors:
Price Targets
NEULANDLAB
Neuland Laboratories Ltd
38% Upside
3933
United Laboratories International Holdings Ltd
60% Upside
CLN
Celon Pharma SA
34% Upside
AHEALTH
Apex Healthcare Bhd
11% Downside
AETHER
Aether Industries Ltd
23% Upside
GSK
GlaxoSmithKline PLC
3% Upside
600867
Tonghua Dongbao Pharmaceutical Co Ltd
35% Upside
000756
Shandong Xinhua Pharmaceutical Co Ltd
29% Downside

Revenue
Forecast

Revenue Estimate
Cadrenal Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Cadrenal Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Cadrenal Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CVKD's stock price target?
Price Target
36.38 USD

According to Wall Street analysts, the average 1-year price target for CVKD is 36.38 USD with a low forecast of 30.3 USD and a high forecast of 47.25 USD.

Back to Top